These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26087562)

  • 21. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth.
    Liu S; Yuan Y; Okumura Y; Shinkai N; Yamauchi H
    Biochem Biophys Res Commun; 2010 Apr; 394(2):297-302. PubMed ID: 20206136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro mechanism of PC SPES.
    Chenn S
    Urology; 2001 Aug; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action mechanism and signal pathways of Psidium guajava L. aqueous extract in killing prostate cancer LNCaP cells.
    Chen KC; Peng CC; Chiu WT; Cheng YT; Huang GT; Hsieh CL; Peng RY
    Nutr Cancer; 2010; 62(2):260-70. PubMed ID: 20099201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
    Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
    Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .
    Kubota T; Hisatake J; Hisatake Y; Said JW; Chen SS; Holden S; Taguchi H; Koeffler HP
    Prostate; 2000 Feb; 42(3):163-71. PubMed ID: 10639186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
    Ishikura N; Kawata H; Nishimoto A; Nakamura R; Tsunenari T; Watanabe M; Tachibana K; Shiraishi T; Yoshino H; Honma A; Emura T; Ohta M; Nakagawa T; Houjo T; Corey E; Vessella RL; Aoki Y; Sato H
    Int J Oncol; 2015 Apr; 46(4):1560-72. PubMed ID: 25634071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.
    Ye F; Jiang S; Volshonok H; Wu J; Zhang DY
    Nutr Cancer; 2007; 57(1):100-10. PubMed ID: 17516867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chinese herbal medicine PC-SPES II induces the apoptosis of androgen-independent prostate carcinoma cell line PC-3].
    Du G; Zhang ZW; Zhang YK; Guo JM
    Zhonghua Nan Ke Xue; 2007 Jun; 13(6):563-7. PubMed ID: 17615985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.
    Ikezoe T; Chen SS; Heber D; Taguchi H; Koeffler HP
    Prostate; 2001 Dec; 49(4):285-92. PubMed ID: 11746275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of matrine on the expression of PSA and AR in prostate cancer cell line LNCaP.
    Chen K; Hu Z; Wang T; Guo H; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):697-9. PubMed ID: 19107370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.
    Lu Y; Feng F; Yang Y; Gao X; Cui J; Zhang C; Zhang F; Xu Z; Qv J; Wang C; Zeng Z; Zhu Y; Yang Y
    Cell Signal; 2013 Feb; 25(2):479-89. PubMed ID: 23153584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.